pharma · Inflammatory Bowel Disease (IBD) · Melanoma · IRON
Disc Medicine
Disc Medicine is a pharma organization headquartered in Watertown, USA. It trades on NYSE under ticker IRON. Primary therapeutic focus areas include Inflammatory Bowel Disease (IBD), Melanoma, Parkinson's disease, Falcip
321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US HQ
165 Employees
Public company Type
IRON · NYSE Ticker
Company details
- Status
- Public
- HQ
- 321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US
- Employees
- 165
- Programs
- 308
- Drugs
- 443
- Patents
- 706
Nexviadyme 100 mg powder for concentrate for solution for infusion
Approved · small molecule · Glycogen storage disease type II or acid maltase deficiency, Pompe disease
Nexviadyme 100 mg powder for concentrate for solution for infusion for Glycogen storage disease type II or acid maltase deficiency, Pompe disease is a Approved program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Internal code GZ-2016-11512
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Disc Medicine
- Phase
- Approved
- Modality
- small_molecule
- Indication
- Glycogen storage disease type II or acid maltase deficiency, Pompe disease
- Status
- active
- Trials
- 1